972 filings
Page 7 of 49
CORRESP
bqaxjvh6o82n797cown
28 Apr 22
Correspondence with SEC
12:00am
UPLOAD
16obj1
26 Apr 22
Letter from SEC
12:00am
8-K
gmkk0m
12 Apr 22
Acer Therapeutics and Relief Therapeutics Announce Presentation of ACER-001 Data at the Society for Inherited Metabolic Disorders Annual Meeting
9:00am
8-K
7ld1ocy4
6 Apr 22
Other Events
4:04pm
8-K
ijyczkpc6 97oahmqb5a
4 Apr 22
Acer Therapeutics’ EDSIVO™ (celiprolol) Granted FDA Breakthrough Therapy Designation for Vascular Ehlers-Danlos Syndrome
9:23am
8-K
bnvozvf n35nlkomcu5
31 Mar 22
Other Events
9:00am
8-K
zqcbp
30 Mar 22
Results anticipated in H2 2022
4:02pm
8-K
lfu3actcdlzyntg zm
16 Mar 22
Regulation FD Disclosure
4:05pm
8-K
xr8l61my4sc
7 Mar 22
Acer Therapeutics Secures up to $48.5 Million in Convertible Note and Secured Loan Financing Facilities
6:18am
S-8
jq95pxumc6v4jb4bf
2 Mar 22
Registration of securities for employees
5:45pm
8-K
80vqeeb0r 6s
2 Mar 22
Acer Therapeutics Reports Q4 and Full Year 2021 Financial Results and Provides Corporate Update
5:23pm
4
lbgfis yoddh6uzr1
23 Feb 22
Acer Therapeutics / Adrian W Quartel ownership change
4:39pm
3
fojq4oi 5xc2bz2vx
23 Feb 22
Acer Therapeutics / Adrian W Quartel ownership change
4:37pm
8-K
vh4e09
22 Feb 22
Acer Therapeutics Announces Appointment of Adrian Quartel, M.D., FFPM, as Chief Medical Officer
9:00am
SC 13G/A
7qyze13
14 Feb 22
Acer Therapeutics / Nantahala Capital Management ownership change
8:00am
8-K
d3tz0 tb0q6
27 Jan 22
Acer Therapeutics and Relief Therapeutics Announce Presentation of
4:05pm
4
7lfhmnyv8xqf8
21 Jan 22
Acer Therapeutics / Bernard H Paul ownership change
4:07pm